UFP Technologies

UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The firm manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It’s single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The firm also providing highly engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. Its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEWBURYPORT, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum to be held virtually on March 19 and 20, 2024. UFP's presentation is scheduled to begin at 9:45 AM ET on Wednesday, March 20, 2024.

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum

NEWBURYPORT, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $44.9 million or $5.83 per diluted common share outstanding for its year ended December 31, 2023, compared to net income of $41.8 million or $5.45 per diluted common share outstanding for 2022. Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million.

UFP Technologies Announces Record 2023 Results

NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company's MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer.

Mitchell Rock Named President of UFP Technologies

NEWBURYPORT, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming CJS Securities 24th Annual “New Ideas for the New Year” Conference to be held virtually on January 10, 2024. UFP's presentation is scheduled to begin at 11:45 AM ET on Wednesday, January 10, 2024.

UFP Technologies to Present and Host 1X1 Investor Meetings at the CJS Securities 24th Annual “New Ideas for the New Year” Virtual Conference

NEWBURYPORT, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R.

UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 35th Annual Healthcare Conference

UFP Technologies, Inc., a niche manufacturer in the healthcare space, has seen its stock decline by 30% from its recent highs. The company has transformed itself into a more focused firm via a series of small acquisitions and one divesture. There was some heavy insider selling in the stock in May and August of this year, but last week an insider made a small purchase in the stock.

A First Look At UFP Technologies

NEWBURYPORT, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported that adjusted net income increased 13.8% to $11.9 million in the third quarter of 2023 from $10.4 million in the third quarter of 2022. Sales for the third quarter were $100.8 million compared to 2022 third quarter sales of $97.0 million. Adjusted net income increased 44.4% to $35.8 million for the nine-month period ended September 30, 2023 from $24.8 million in the same period of 2022. Sales for the nine-month period ended September 30, 2023 were $298.6 million compared to sales of $262.6 million in the same period in 2022. Adjusted net income is a non-GAAP term. Please see “Non-GAAP Financial Information” at the end of this news release.

UFP Technologies Announces Strong Q3 2023 Results

UFP Technologies, Inc. presents compelling long-term value with strong business growth and high returns on investment. The company's Q2 earnings showed positive sales trends in various markets, particularly in the medical devices segment. The company presents with a wide margin of safety based on its economic growth factors.

UFP Technologies: Selloff Presents Asymmetrical Payoff From Economic Leverage On Capital

NEWBURYPORT, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Midwest IDEAS Investor Conference on August 23, 2023. UFP Technologies' presentation is scheduled to begin at 9:20 AM CT on August 23. The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com/Investors.

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Midwest IDEAS Investor Conference August 23

NEWBURYPORT, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $11.9 million or $1.55 per diluted common share outstanding for its second quarter ended June 30, 2023, compared to net income of $8.9 million or $1.17 per diluted common share outstanding for the same quarter in 2022. Sales for the second quarter were $100.0 million compared to sales of $94.3 million in the second quarter of 2022. Net income for the six-month period ended June 30, 2023 was $21.6 million or $2.81 per diluted common share outstanding compared to $13.8 million or $1.81 per diluted common share outstanding for the same period in 2022. Sales for the six-month period ended June 30, 2023 were $197.8 million compared to sales of $165.6 million for the same period in 2022.

UFP Technologies Announces Record Q2 Results

Bill.com

Super Micro Computer

Stocks like Apple (NASDAQ: AAPL ) and Amazon (NASDAQ: AMZN ) inspire investors to hold onto stocks for the long term. Investors who bought and held shares in the late 1990s or early 2000s saw their wealth increase significantly.

These 3 Stocks Are Flying High, But Can Still Triple From Here

UFPT Technologies has caught another strong bid in FY'23. The company's MedTech business, particularly its robotic surgery sales, is driving its success, with the potential to capture market share in the future. Despite a possible short-term correction, I've revised up the long-term target for UFPT to $342/share.

UFP Technologies: Exceptional, Durable Economic Characteristics

Aehr Test Systems

Array Technologies

The top growth stocks below have all performed extraordinarily well over the trailing twelve months. During that time, they've undoubtedly created millionaires.

Invest Like a Millionaire With These Top 3 Growth Stocks

NEWBURYPORT, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world. The Company's single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. The Company today announced that Chairman & Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on June 14-15, 2023.

UFP Technologies, Inc. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on June 14, 2023

NEWBURYPORT, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $9.7 million or $1.27 per diluted common share outstanding for its first quarter ended March 31, 2023, compared to net income of $4.9 million or $0.64 per diluted common share outstanding for the first quarter of 2022. Net Sales for the first quarter were $97.8 million compared to 2022 first quarter sales of $71.2 million.

UFP Technologies Announces Record Q1 2023 Results

NEWBURYPORT, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced that Chairman & Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023.

UFP TECHNOLOGIES, INC. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on March 22, 2023

NEWBURYPORT, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $41.8 million or $5.45 per diluted common share outstanding for its year ended December 31, 2022, compared to net income of $15.9 million or $2.09 per diluted common share outstanding for 2021. Net Sales for 2022 were $353.8 million compared to 2021 sales of $206.3 million.

UFP Technologies Announces Record 2022 Results

Advanced Micro Devices

Chipotle

New York Times

Old Dominion Freight Line

Polaris

Ferrari

While volatility persists, markets have managed to get off to a strong start in 2023. All three of the major U.S. stock indices are positive on the year, with the technology-laden Nasdaq leading the pack with a 14% year-to-date gain.

7 Stocks to Watch if You're Looking for the Next High Flyer

UFP Technologies continues its upward trajectory along the equity curve. Valuations still make sense on closer inspection, and investors are looking at a fair P/E of ~24.25x by estimation.

UFP Technologies: Further Re-Rating In FY 2023 More Than Possible

NEWBURYPORT, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Southwest IDEAS Investor Conference on November 16, 2022. UFP Technologies' presentation is scheduled to begin at 3:00 pm CT on November 16. The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com/Investors.

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Southwest IDEAS Investor Conference November 16

NEWBURYPORT, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $19.5 million or $2.56 per diluted common share outstanding for its third quarter ended September 30, 2022, compared to net income of $3.8 million or $0.50 per diluted common share outstanding for the same quarter in 2021. Sales for the third quarter were $97.0 million compared to 2021 third quarter sales of $50.7 million. Net income for the nine-month period ended September 30, 2022 was $33.3 million or $4.37 per diluted common share outstanding compared to $12.7 million or $1.67 per diluted common share outstanding for the same period in 2021. Sales for the nine-month period ended September 30, 2022 were $262.6 million compared to sales of $150.0 million for the same period in 2021.

UFP Technologies Announces Record Q3 2022 Results

NEWBURYPORT, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- UFP Technologies (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products and packaging primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and CEO and Ronald J. Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will participate in the Sidoti September Small-Cap Virtual Conference on September 21, 2022. UFP Technologies' presentation will begin at 10:00 am ET on September 21, 2022 and can be accessed live at https://sidoti.zoom.us/webinar/register/WN_ysoqK5utQO6L9oId0mVIOA. It is also accessible in the investor relations section of the Company's website: www.ufpt.com. UFP Technologies will also host virtual one-on-ones with investors on Wednesday, September 21, 2022. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and you don't need to be a Sidoti client.

UFP Technologies to Present and Host 1X1 Investor Meetings at the Sidoti September Small-Cap Virtual Conference

UFP Technologies exhibits the kind of equity premia we are seeking exposure to in FY22. A 5-year normalized ROIC of 9.2% coupled with a pivot into medtech look to have positioned the company well looking ahead.

UFP Technologies: Molded Fiber Sale Adds ~$1.60/Share To Bottom-Line

NEWBURYPORT, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (“UFP”) (Nasdaq: UFPT) today announced the sale of its molded fiber business and related real estate in Iowa to CKF, Inc. for approximately $32 million.

UFP Technologies Sells Molded Fiber Business to CKF, Inc.

NEWBURYPORT, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) today announced the opening of a new medical manufacturing operation in Tijuana, Mexico. The 84,000-square-foot, FDA-registered facility will feature clean room and clean space medical device manufacturing and assembly.

News for UFP Technologies Stock (UFPT)